/r/nasdaq
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
Mark as read: Add to a list
Mark as read: Add to a list
Today's $AGBA Update: Once the AGBA/Triller merger is complete, our company will focus on four key verticals!
Mark as read: Add to a list
OCTO - Paul Vassilakos, CEO of Eightco and President of Forever 8 Fund, LLC (“Forever 8”), the Company’s largest subsidiary, said “The Company has a clear focus on prioritizing the Forever 8 business providing inventory capital for e-commerce sellers and refurbished apple product sellers.
Mark as read: Add to a list
Mark as read: Add to a list
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)
Mark as read: Add to a list
Mark as read: Add to a list
Mark as read: Add to a list